Monsanto’s NemaStrikeTM Technology Approved by EPA

Farmers to Gain Innovative Seed Treatment Technology to Control Nematodes

Category:

Monday May 1, 2017

Dateline:

ST. LOUIS

Public Company Information:

NYSE:
MON
"We work to provide farmers with highly effective and easy-to-use management tools to protect the health and potential of their crops. In 2018, NemaStrike Technology will provide breakthrough yield protection technology to farmers across the United States."

ST. LOUIS--(BUSINESS WIRE)--Monsanto Company (NYSE: MON) announced today that the U.S. EPA issued registration for tioxazafen, which is branded as NemaStrikeTM Technology. This approval will enable farmers to realize the nematode control benefits of the technology in 2018, pending state approvals.

NemaStrike Technology, a nematicide that will be offered as part of Acceleron® Seed Applied Solutions, will offer a novel mode of action that stays in the root zone where nematodes attack. NemaStrike Technology will provide broad-spectrum control of plant parasitic nematodes and consistent yield protection performance in corn, soybeans, and cotton.

“This blockbuster technology will be a game-changing addition to our seed applied solutions portfolio by providing a novel solution to a yield robbing pest,” said Brett Begemann, Monsanto President and Chief Operating Officer. “We work to provide farmers with highly effective and easy-to-use management tools to protect the health and potential of their crops. In 2018, NemaStrike Technology will provide breakthrough yield protection technology to farmers across the United States.”

Plant parasitic nematodes are microscopic roundworms in the soil that steal corn, soybean, and cotton yields by feeding on plant roots, facilitating bacterial and fungal infections, and spreading viruses. Nematode damage is often mistaken as other issues in the field, so growers do not always recognize they have a problem. However, EPA has stated that plant parasitic nematodes cause an estimated 14 percent loss in agriculture production worldwide, with $80-100 billion worth of crop losses every year globally.*

Over the last three years in Monsanto product development field trials, NemaStrike Technology provided a yield protection performance advantage over the competitive standard of 7 bushels per acre with a 73 percent positive response rate in corn, 3 bushels per acre with a 68 percent positive response rate in soybeans, and 80 lbs. lint per acre with an 86 percent positive response rate in cotton (results varied based on nematode pressure in each field).

“Nematodes are a real concern, and farmers may be significantly underestimating the damage nematodes are causing to their crops,” said Jared Thomas, Monsanto North America seed applied solutions portfolio manager. “Monsanto offers a variety of seed applied solutions today, and we’re always working to develop new options for farmers. We’re focused on helping farmers protect the potential of their crops with tools that can fit into their overall strategy for managing pests.”

Please visit www.NemaStrikeTechnology.com to stay up to date on the technology.

*Source: Review of the Benefits of Proposed Tioxazafen Registration as a Seed Treatment Nematicide in Com, Cotton, and Soybeans; Office of Chemical Safety and Pollution Prevention; United States Environmental Protection Agency; Jan. 17, 2017.

About Monsanto Company

Monsanto is committed to bringing a broad range of solutions to help nourish our growing world. We produce seeds for fruits, vegetables and key crops – such as corn, soybeans, and cotton – that help farmers have better harvests while using water and other important resources more efficiently. We work to find sustainable solutions for soil health, help farmers use data to improve farming practices and conserve natural resources, and provide crop protection products to minimize damage from pests and disease. Through programs and partnerships, we collaborate with farmers, researchers, nonprofit organizations, universities and others to help tackle some of the world’s biggest challenges. To learn more about Monsanto, our commitments and our more than 20,000 dedicated employees, please visit: discover.monsanto.com and monsanto.com. Follow our business on Twitter® at twitter.com/MonsantoCo, on the company blog, Beyond the Rows® at monsantoblog.com or subscribe to our News Release RSS Feed.

ALWAYS READ AND FOLLOW LABEL DIRECTIONS. PRODUCTS FEATURING NEMASTRIKE™ TECHNOLOGY MAY NOT BE APPROVED IN ALL STATES. Contact your state pesticide regulatory agency regarding the approval status of tioxazafen products for application to seeds in your state. Acceleron® and NemaStrike™ are trademarks of Monsanto Technology LLC. All other trademarks are the property of their respective owners. ©2017 Monsanto Company.

Contact:

Monsanto Company
Media:
Jeff Neu, 314-694-4690
or
Christi Dixon, 314-694-1092
or
Investors:
Laura Meyer, 314-694-8148